119 related articles for article (PubMed ID: 15797258)
1. Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium.
Chen P; Hu S; Yao J; Moore SA; Spector AA; Fang X
Microvasc Res; 2005 Jan; 69(1-2):28-35. PubMed ID: 15797258
[TBL] [Abstract][Full Text] [Related]
2. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of anandamide in cerebral microvascular endothelial cells.
Chen P; Hu S; Harmon SD; Moore SA; Spector AA; Fang X
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):59-72. PubMed ID: 15165032
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
Kim J; Watkins BA
J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
[TBL] [Abstract][Full Text] [Related]
6. R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism.
Ramer R; Brune K; Pahl A; Hinz B
Biochem Biophys Res Commun; 2001 Sep; 286(5):1144-52. PubMed ID: 11527419
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes.
Van Dross RT
Mol Carcinog; 2009 Aug; 48(8):724-32. PubMed ID: 19148897
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
9. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide.
Kozak KR; Prusakiewicz JJ; Rowlinson SW; Prudhomme DR; Marnett LJ
Biochemistry; 2003 Aug; 42(30):9041-9. PubMed ID: 12885237
[TBL] [Abstract][Full Text] [Related]
10. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
11. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
[TBL] [Abstract][Full Text] [Related]
12. The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.
Oz M; Jaligam V; Galadari S; Petroianu G; Shuba YM; Shippenberg TS
J Neurochem; 2010 Mar; 112(6):1454-64. PubMed ID: 20050977
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
14. Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid.
Ronco AM; Llanos M; Tamayo D; Hirsch S
Pharmacology; 2007; 79(1):12-6. PubMed ID: 17114903
[TBL] [Abstract][Full Text] [Related]
15. Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation.
Karaliota S; Siafaka-Kapadai A; Gontinou C; Psarra K; Mavri-Vavayanni M
Obesity (Silver Spring); 2009 Oct; 17(10):1830-8. PubMed ID: 19543211
[TBL] [Abstract][Full Text] [Related]
16. Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides.
Soliman E; Henderson KL; Danell AS; Van Dross R
Mol Carcinog; 2016 Feb; 55(2):117-30. PubMed ID: 25557612
[TBL] [Abstract][Full Text] [Related]
17. Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).
Correa F; Docagne F; Clemente D; Mestre L; Becker C; Guaza C
Biochem J; 2008 Feb; 409(3):761-70. PubMed ID: 17961121
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Lam FF; Luk PW; Ng ES
Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus.
Kim J; Alger BE
Nat Neurosci; 2004 Jul; 7(7):697-8. PubMed ID: 15184902
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 prostaglandins mediate anandamide-inhibitory action on nitric oxide synthase activity in the receptive rat uterus.
Sordelli MS; Beltrame JS; Cella M; Franchi AM; Ribeiro ML
Eur J Pharmacol; 2012 Jun; 685(1-3):174-9. PubMed ID: 22554772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
